NCT00029692

Brief Summary

This study will assess the effects of ginseng and ginkgo on 1) cognitive function, 2) enzymes that process drugs, and 3) enzymes that may help prevent cancer.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for phase_2 healthy

Timeline
Completed

Started Mar 2002

Typical duration for phase_2 healthy

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 18, 2002

Completed
3 days until next milestone

First Posted

Study publicly available on registry

January 21, 2002

Completed
1 month until next milestone

Study Start

First participant enrolled

March 1, 2002

Completed
3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2005

Completed
Last Updated

July 26, 2006

Status Verified

July 1, 2006

First QC Date

January 18, 2002

Last Update Submit

July 24, 2006

Conditions

Healthy

Interventions

GinsengDRUG
GinkgoDRUG

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Acceptable weight and laboratory test values
  • Abuse of drugs, tobacco, or alcohol
  • Chronic physical complaints or serious allergies
  • Illnesses requiring chronic drug ingestion
  • Use of herbs, high-dose vitamins, or non-traditional diets

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Kansas Medical Center

Kansas City, Kansas, 66160, United States

Location

MeSH Terms

Interventions

Asian ginsengGinkgo Extract

Intervention Hierarchy (Ancestors)

Plant ExtractsPlant PreparationsBiological ProductsComplex Mixtures

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
DOUBLE
Purpose
TREATMENT
Sponsor Type
NIH

Study Record Dates

First Submitted

January 18, 2002

First Posted

January 21, 2002

Study Start

March 1, 2002

Study Completion

March 1, 2005

Last Updated

July 26, 2006

Record last verified: 2006-07

Locations

US(1)